Nutrition Imbalances, Malnutrition, Malabsorption, Cachexia, Anorexia, Sarcopenia are the most common disease during cancer treatment, Leading to Increased Basal Metabolic Rate. All these Greatly impacts the quality of life (QOL)of patients and subsequently impact on mortality rates or even promotes discontinuation of treatment leading to less survival again. As per WHO report about 25% of cancer patients die mainly because of Malnourishment and lack of supplementation which are induced either by the disease or by the therapy itself.

EON Therapy addresses the above problem holding Nutritional imbalances as major cause approaching the cancer stage specific supplementation . This approach has never been applied in comprehensive way which considers significantly the drug nutrients interactions, toxicity level of drugs use to complement main therapy.

Novel Nutrition, which works on new nutritional therapies (including prescribed medicines) for specific diseases & conditions that would be administered by a health professional, which aims to address various health conditions with an emphasis on “Nutrition to address cancer and comorbid conditions”

Solution – EON supportive nutrition portfolio provides tissue specific nutrition formulation, addresses the tissue diversity based metabolism and nutrient uptake responsible for suboptimal main therapy outcome. Hence the underlying pathological conditions can be corrected with such research-based solution which emphasize the physiological importance of tissue specific nutrition requirement.